Galecto Inc
Change company Symbol lookup
Select an option...
GLTO Galecto Inc
ERNA Eterna Therapeutics Inc
TANH Tantech Holdings Ltd
OMGA Omega Therapeutics Inc
INBS Intelligent Bio Solutions Inc
PAYX Paychex Inc
PYR Pyrogenesis Canada Inc
PM Philip Morris International Inc
GWAV Greenwave Technology Solutions Inc
SLNO Soleno Therapeutics Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Galecto, Inc. is a clinical-stage biotechnology company. The Company is focused on developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The Company’s initial focus is on the development of small molecule inhibitors of galectin-3 and lysyl oxidase-like 2 (LOXL2). The Company is developing GB0139 for the treatment of Idiopathic Pulmonary Fibrosis (IPF), a life-threatening progressive fibrotic disease of the lung. The Company’s product candidate also includes GB1211, a selective oral small molecule inhibitor of galectin-three, is chemically distinct from GB0139 and is being developed for the treatment of various oncology indications and liver cirrhosis, and GB2064 is a selective oral small molecule inhibitor of LOXL2 for the treatment of myelofibrosis, a malignant disease of the bone marrow in which progressive fibrosis reduces the ability to form blood cells in the bone marrow.

Closing Price
$0.698
Day's Change
0.127 (22.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.75
Day's Low
0.635
Volume
(Heavy Day)
Volume:
10,798,957

10-day average volume:
1,610,930
10,798,957

General Motors Co. Stock Underperforms Wednesday When Compared To Competitors

4:57 pm ET May 10, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of General Motors Co. (GM) dropped 0.60% to $33.08 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.45% to 4,137.64 and the Dow Jones Industrial Average falling 0.09% to 33,531.33.

This was the stock's second consecutive day of losses.

General Motors Co. closed $10.55 below its 52-week high ($43.63), which the company reached on February 16th.

The stock underperformed when compared to some of its competitors Wednesday, as Tesla Inc. (TSLA) fell 0.36% to $168.54.

Trading volume (15.4 M) eclipsed its 50-day average volume of 14.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 10, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

May 10, 2023 16:57 ET (20:57 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.